Last reviewed · How we verify
Ivermectin Tablets
At a glance
| Generic name | Ivermectin Tablets |
|---|---|
| Also known as | Iverzine |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) (PHASE2)
- HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation (PHASE1)
- Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole (PHASE3)
- Ivermectin Repurposed for the Treatment of PKDL (EARLY_PHASE1)
- Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis (PHASE3)
- Ivermectin Safety in Small Children (PHASE2)
- Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases (PHASE4)
- ACTIV-6: COVID-19 Study of Repurposed Medications (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |